We now have two FDA-approved disease-modifying treatments for Alzheimer's disease, and hundreds of clinical trials are ...

His geriatric doctor said "no" to prescribing medication to help slow down the disease. The doctor said his pulse rate is low ...

The Food and Drug Administration (FDA) has approved a new maintenance dosing schedule for Leqembi, a monoclonal antibody ...

The next Alzheimer’s treatment could come from an unexpected place. In new research released this week, scientists have found ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

A pathway once considered fundamental in Alzheimer’s disease is being studied intensely again, and may soon result in safer, ...

SaveHealth provides an overview of Alzheimer's disease, including treatment and coping mechanisms for those with the disease ...

University of Oklahoma's Dr. Sreemathi Logan leads a study on dementia, backed by a $2.2 million grant, focusing on aging, ...

Able to cross the blood-brain barrier, Xenon gas seemed to perk the mice right up, which began to become particularly active ...

A London clinic has become the first in Europe to roll out two Alzheimer’s wonder drugs privately after they were rejected ...

Jan. 15, 2025 — Most treatments being pursued today to protect against Alzheimer's disease focus on amyloid plaques and tau tangles that accumulate in the brain, but new research points to a ...

Drugs targeting amyloid plaques have failed to show efficacy in clinical trials. A new approach is needed to tackle AD ...